Could the answer to NAFLD be hidden in diabetic therapy? The impact of T2DM treatment on NAFLD [0.03%]
治疗2型糖尿病对非酒精性脂肪肝病的影响，这是否意味着治疗NAFLD的新思路？
Vicki Shah,Thomas Colletti,Nancy Reau
Vicki Shah
1_y9j1w5u5Kaltura. Copyright © 2024 American Association for the Study of Liver Diseases.
Allison J Kwong,Joshua Norman,Scott W Biggins
Allison J Kwong
Jennifer Guy
Jennifer Guy
Wilson disease and pregnancy [0.03%]
威尔森病与妊娠
David Weinstein,Dhiren A Shah
David Weinstein
Mette M Lauridsen,Jasmohan S Bajaj
Mette M Lauridsen
Nathalie A Pena Polanco,Cynthia Levy
Nathalie A Pena Polanco
Anahita Rabiee,Atoosa Rabiee
Anahita Rabiee
Muscle cramps in cirrhosis [0.03%]
肝硬化患者的肌肉痉挛
Juan J Gonzalez,Elliot B Tapper
Juan J Gonzalez
Kyla M Tolliver,Erin J Phipps
Kyla M Tolliver
Screening for hepatitis C as part of an opioid stewardship quality improvement initiative: Identifying infected patients and analyzing linkage to care [0.03%]
作为阿片类药物管理质量改进计划的一部分的丙型肝炎筛查：识别感染患者并分析治疗联系
Rebekah B DeCamillis,Aliza L Hekman,David H Priest
Rebekah B DeCamillis
Screening patients with opioid use disorder (OUD) for HCV can potentially decrease morbidity and mortality if HCV-infected individuals are linked to care. We describe a quality improvement initiative focused on patients with OUD, incorporat...